✦ LIBER ✦

11-P: Impact of Low Level Donor Specific Antibodies in Renal Transplant Outcomes

✍ Scribed by Ty B. Dunn; Harriet Noreen; David Maurer; Ozlem G. Ozturk; Kristen Gillingham; Arthur J. Matas; Robert A. Bray; Howard M. Gebel

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

51-W: Transplant outcome in patients wit

✍ Julie A. Houp; Leisel S. Martin; Joseph K. Melancon; Robert A. Montgomery; Mary 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 31 KB

106-P: Transplant outcomes in patients w

✍ Denise Pochinco; Dawn Kelm; Hacking Kendra; Tom Blydt-Hansen; David Rush; Ian Gi 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 41 KB

Baseline Donor-Specific Antibody Levels

✍ J. M. Gloor; J. L. Winters; L. D. Cornell; L. A. Fix; S. R. DeGoey; R. M. Knauer 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 247 KB

The Presence of Donor-Specific Antibodie

✍ Tozkir, H.; Sağiroğlu, T.; Kiliçarslan-Ayna, T.; Tan, S.; Çopuroğlu, E.; Sağiroğ 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 92 KB

Impact of donor-specific antibodies in r

✍ Jeremy Goodman; Martin D Jendrisak; Surendra Shenoy; Donna Phelan; Jeffrey A Low 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 27 KB

49-P: Clinical Relevance of Pretransplan

✍ Eun Young Song; Yu-joo Lee; Shin Young Joo; Jung Won Hyun; Yon Su Kim; Jongwon H 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 85 KB